These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2872800)

  • 21. Do beta-blockers alter lipids and what are the consequences?
    Holtzman E; Rosenthal T; Goldbourt U; Segal P
    J Cardiovasc Pharmacol; 1987; 10 Suppl 2():S86-92; discussion S93. PubMed ID: 2481177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alpha 1 blockers. Safe, effective treatment for hypertension.
    Itskovitz HD
    Postgrad Med; 1991 Jun; 89(8):89-92, 95-8, 103-6, passim. PubMed ID: 1674822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antihypertensive therapy and modification of metabolic risk factors (glucose and lipid metabolism)].
    Klein W
    Z Kardiol; 1992 Jun; 81(6):295-302. PubMed ID: 1353932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination antihypertensive therapy with terazosin and other antihypertensive agents: results of clinical trials.
    Pool JL
    Am Heart J; 1991 Sep; 122(3 Pt 2):926-31. PubMed ID: 1678924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic considerations in the choice of therapy for the patient with hypertension.
    Black HR
    Am Heart J; 1991 Feb; 121(2 Pt 2):707-15. PubMed ID: 1671190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diuretics and beta-blockers: is there a risk for dyslipidemia?
    Weir MR; Moser M
    Am Heart J; 2000 Jan; 139(1 Pt 1):174-83. PubMed ID: 10618579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alpha-1-adrenergic blockade and lipoprotein metabolism in essential hypertension.
    Ferrier C; Beretta-Piccoli C; Weidmann P; Mordasini R
    Clin Pharmacol Ther; 1986 Nov; 40(5):525-30. PubMed ID: 2876796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The diuretic dilemma and the management of mild hypertension.
    Moser M
    Drugs; 1986; 31 Suppl 4():56-67. PubMed ID: 3525090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are we misunderstanding beta-blockers.
    Cruickshank JM
    Int J Cardiol; 2007 Aug; 120(1):10-27. PubMed ID: 17433471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interactions between antihypertensive agents, serum lipids and cigarette smoking in high risk hypertensive patients.
    Plouin PF
    J Hum Hypertens; 1989 Dec; 3 Suppl 2():49-53; discussion 53-4. PubMed ID: 2575176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alpha- and beta-receptor blocking drugs in the treatment of hypertension.
    Ram CV; Kaplan NM
    Curr Probl Cardiol; 1979 Jan; 3(10):1-53. PubMed ID: 40755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The diuretic dilemma and the management of mild hypertension.
    Moser M
    J Clin Hypertens; 1986 Jun; 2(2):195-202. PubMed ID: 3531420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diuretics in long-term treatment of hypertension: a comparison to beta-blockers.
    Berglund G
    J Cardiovasc Pharmacol; 1984; 6 Suppl 1():S256-9. PubMed ID: 6204151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The place of alpha blockers in the treatment of hypertension.
    Reid JL
    Clin Exp Hypertens; 1993 Nov; 15(6):1291-7. PubMed ID: 7903577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The case for beta-blockers as first-line antihypertensive therapy.
    Cruickshank JM
    J Hypertens Suppl; 1992 Jun; 10(3):S21-7. PubMed ID: 1353111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of antihypertensive and lipid actions of terazosin and atenolol in essential hypertension.
    Silke B; Guy S; Humphreys JE
    J Hum Hypertens; 1992 Jun; 6(3):221-5. PubMed ID: 1352828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of carvedilol on serum lipids in patients with essential hypertension.
    Goto Y; Tamachi H; Fusegawa Y; Nakaya N; Homma Y; Mikami M; Iori S; Yamazaki A
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S45-50. PubMed ID: 1721979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of alpha-adrenergic and beta-adrenergic receptor blockade on lipid metabolism.
    Ferrara LA; Marotta T; Rubba P; De Simone B; Leccia G; Soro S; Mancini M
    Am J Med; 1986 Feb; 80(2A):104-8. PubMed ID: 2868656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antihypertensive agents and cardiovascular risk factors.
    Fodor JG
    Clin Ther; 1986; 8(5):490-509. PubMed ID: 2876774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
    JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.